---
title: "The RMR Group Inc. Q2 Profit Declines"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285479991.md"
description: "The RMR Group Inc. reported a decline in Q2 earnings, with a profit of $1.01 million ($0.05 per share), down from $3.62 million ($0.21 per share) last year. Adjusted earnings were $2.21 million ($0.11 per share). Revenue fell 12.6% to $145.63 million from $166.67 million in the previous year."
datetime: "2026-05-07T03:45:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285479991.md)
  - [en](https://longbridge.com/en/news/285479991.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285479991.md)
generator: "portal-rs"
---

# The RMR Group Inc. Q2 Profit Declines

(RTTNews) - The RMR Group Inc. (RMR) announced earnings for second quarter that Drops, from last year

The company's bottom line came in at $1.01 million, or $0.05 per share. This compares with $3.62 million, or $0.21 per share, last year.

Excluding items, The RMR Group Inc. reported adjusted earnings of $2.21 million or $0.11 per share for the period. 

The company's revenue for the period fell 12.6% to $145.63 million from $166.67 million last year.

The RMR Group Inc. earnings at a glance (GAAP) :

-Earnings: $1.01 Mln. vs. $3.62 Mln. last year. -EPS: $0.05 vs. $0.21 last year. -Revenue: $145.63 Mln vs. $166.67 Mln last year. 

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

### Related Stocks

- [RMR.US](https://longbridge.com/en/quote/RMR.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)

## Related News & Research

- [GRAPHIC-Traders are bracing for an increasingly hawkish ECB](https://longbridge.com/en/news/296744183.md)
- [Strattec Security Non-GAAP EPS of $2.06 beats by $0.70, revenue of $151.8M beats by $5.03M](https://longbridge.com/en/news/296953877.md)
- [Higher Interest Rates Could Lift These Overlooked US Regional Bank Stocks](https://longbridge.com/en/news/297007990.md)
- [NewAmsterdam Pharma to present Phase 3 obicetrapib trial data at ESC Congress 2026](https://longbridge.com/en/news/297041595.md)
- [3 Defensive Dividend Stocks for Higher Rates and Steady Income](https://longbridge.com/en/news/296830944.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**